// App-Quantinova.ai

: Age, Albumin, and LDH Predict Outcome of Patients with Limited Stage Peripheral T Cell Lymphoma: A Prognostic Model Developed on 244 Cases Enrolled in the T Cell Project 1 By the International T Cell Project Network

Researchers

Presenter

  • Greg Hapgood

Principal Investigators

  • Yana Stepanishyna

  • Julie M. Vose

  • Maria Elena Cabrera

  • Ranjana H. Advani

  • Stefano A Pileri

  • Martina Manni

  • Steven M. Horwitz

  • Francine M. Foss

  • Felicitas Hitz

  • John Radford

  • Ivan Dlouhy

  • Carlos S. Chiattone

  • Won-Seog Kim

  • Tetiana Skrypets

  • Arnon Nagler

  • Judith Trotman

  • Stefano Luminari

  • Massimo Federico

Medical Centers

  • Surgical, Medical and Dental Department of Morphological Sciences related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy

  • Hematology, Yale Cancer Center, New Haven, CT

  • Oncology Nucleus, Samaritano Hospital - Higienopolis, Sao Paulo, Brazil

  • Hematopathology Unit, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), CIBERONC, Universitat de Barcelona, Lisbon, Portugal

  • Division of Hematology & Oncology, Department of Internal Medicine, University of Nebraska Medical Center- Fred and Pamela Buffett Cancer Center, Omaha, NE

  • CHIMOMO Department, University of Modena and Reggio Emilia, Modena, Italy

  • Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)

  • Princess Alexandra Hospital, Brisbane, Australia

  • Oncohematology, National Cancer Institute, Kyiv, Ukraine

  • Department of Medicine, Division of Oncology, Stanford University, Stanford, CA

  • Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY

  • Hematology Department, Hospital Del Salvador, Santiago, Chile

  • University of Modena and Reggio Emilia, University of Modena and Reggio Emilia, Modena, Italy

  • Hematology and Bone Marrow Transplant Unit, Chaim Sheba Medical Center, Tel Hashomer, Israel

  • Hematopathology Division, IEO Istituto Europeo di Oncologia IRCCS, Milano, Italy

  • Diagnostic, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Modena, Italy

  • Department of Haematology, Concord Hospital, Concord, Australia

  • Department of Medical Oncology, The University of Manchester, Manchester, United Kingdom

  • Medical Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland

Locations

  • Italy

  • United States

  • Chile

  • Republic of South Korea

  • Brazil

  • Australia

  • Portugal

  • United Kingdom

  • Israel

  • Ukraine

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Peripheral T-cell lymphoma

Biomarkers

  • Anaplastic lymphoma Kinase

  • Lactate dehydrogenase

  • Serine Peptidase Inhibitor, Kazal Type 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved